Corleen M. Roche
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Corleen M. Roche
Corleen M. Roche is recorded as CFO at CG Oncology, Inc. (CGON). Corleen M. Roche was last confirmed as CFO at Immunome Inc. (IMNM) in a filing dated April 20, 2023. CG Oncology, Inc. reported in an 8-K filed July 11, 2025 that Corleen M. Roche resigned as Chief Financial Officer, effective August 5, 2025. The proxy statement of CG Oncology, Inc. reports total compensation of $2,322,299 for Corleen M. Roche in fiscal 2025, including a base salary of $288,890. Disclosed compensation is on record for 4 fiscal years.
“On July 7, 2025, Corleen Roche, Chief Financial Officer of CG Oncology, Inc. (the “Company”) delivered to the Company a 30-day notice of resignation from her position as Chief Financial Officer of the Company.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
-
Start not stated–2023-04-20
Last confirmed by a filing; no departure on record
-
Start not stated–2025-08-05
-
Start not stated–2025-08-05
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at CG Oncology, Inc.
Other people whose current roles at this company are on record from its filings.
- Arthur Kuan CEO
- Jim DeTore CFO
- Ambaw Bellete COO
- Joshua F. Patterson General Counsel
- Robert Lapetina Chief Accounting Officer
- Christina Rossi Board Member
- Victor Tong Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | CG Oncology, Inc. (CGON) | Prior Chief Financial Officer Robert Lapetina (Prior Interim Principal Financial and Accounting Officer) | $288,890 | $2,322,299 |
| 2024 | CG Oncology, Inc. (CGON) | Chief Financial Officer | $446,357 | $9,845,800 |
| 2023 | CG Oncology, Inc. (CGON) | Chief Financial Officer | — | — |
| 2021 | Immunome Inc. (IMNM) | Chief Financial Officer | $282,051 | $3,096,344 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.